I was hoping it might be feasible to get a preliminary read out on efficacy based on numbers they have by the end of this flu season and then continue recruiting in Southern Hemisphere but also recruit additional numbers (for Phase 3) if that flu season is particularly strong.
So start Phase 3 although Phase 2 hasn't been fully completed - although we would have interim efficacy results. Would involve BARDA and FDA coming to the party.
Preliminary efficacy results might also give guidance as to whether they should be spending too much time chasing the 80mg dose. Would this trial be finished already if we were only testing one dosage?
BTA Price at posting:
0.0¢ Sentiment: LT Buy Disclosure: Held
